Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Left Atrial Appendage Closure With WATCHMAN FLX Device in Recurrent Gastrointestinal Bleeding: The GI-FLX Registry

NCT06052358 is registered in ClinicalTrials.gov with Kansas City Heart Rhythm Research Foundation as lead sponsor.

NCT NCT06052358
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06052358 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Left Atrial Appendage Closure With WATCHMAN FLX Device in Recurrent Gastrointestinal Bleeding: The GI-FLX Registry
Lead sponsor
Kansas City Heart Rhythm Research Foundation
Phase
Observational
Overall status
Terminated
Start date
August 23, 2023
Completion date
June 11, 2025
Enrollment
73 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, gi bleeding